Somewhat Favorable News Coverage Somewhat Unlikely to Affect Imax (NYSE:IMAX) Share Price

News stories about Imax (NYSE:IMAX) have trended somewhat positive on Monday, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Imax earned a media sentiment score of 0.14 on Accern’s scale. Accern also assigned headlines about the company an impact score of 45.1690570100818 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Here are some of the news stories that may have impacted Accern’s analysis:

Shares of Imax (IMAX) opened at $22.60 on Monday. Imax has a 12 month low of $17.58 and a 12 month high of $34.60. The firm has a market cap of $1,460.00, a P/E ratio of 226.00, a P/E/G ratio of 1.32 and a beta of 0.93.

Several research firms have recently issued reports on IMAX. ValuEngine downgraded shares of Imax from a “hold” rating to a “sell” rating in a report on Sunday, December 31st. Piper Jaffray Companies lowered shares of Imax from an “overweight” rating to a “neutral” rating and decreased their target price for the company from $28.00 to $21.00 in a research report on Wednesday, January 10th. Wedbush reiterated a “buy” rating and set a $31.00 target price on shares of Imax in a research report on Friday, October 27th. JPMorgan Chase & Co. upgraded shares of Imax from a “neutral” rating to an “overweight” rating in a research report on Friday, October 27th. Finally, B. Riley restated a “buy” rating and issued a $35.00 price target on shares of Imax in a research report on Monday, January 8th. Three analysts have rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the stock. Imax has a consensus rating of “Hold” and an average price target of $29.30.

In other news, insider Mark Welton sold 8,985 shares of the stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $25.81, for a total transaction of $231,902.85. Following the completion of the sale, the insider now owns 16,331 shares of the company’s stock, valued at $421,503.11. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Robert D. Lister sold 3,528 shares of the stock in a transaction on Monday, December 11th. The stock was sold at an average price of $23.97, for a total transaction of $84,566.16. Following the sale, the insider now directly owns 35,594 shares of the company’s stock, valued at approximately $853,188.18. The disclosure for this sale can be found here. Insiders sold 17,050 shares of company stock valued at $425,276 in the last ninety days. Insiders own 18.90% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect Imax (NYSE:IMAX) Share Price” was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another website, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The correct version of this piece can be read at https://www.dispatchtribunal.com/2018/02/19/imax-imax-earning-somewhat-positive-news-coverage-analysis-finds.html.

About Imax

IMAX Corporation is an entertainment technology company. The Company operates through seven segments: IMAX systems; theater system maintenance; joint revenue sharing arrangements; film production and IMAX DMR; film distribution; film post-production, and other. The IMAX systems segment designs, manufactures, sells or leases IMAX theater projection system equipment.

Insider Buying and Selling by Quarter for Imax (NYSE:IMAX)

Receive News & Ratings for Imax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imax and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply